earnings
confidence high
sentiment positive
materiality 0.80
GE HealthCare Q2 beats, raises FY guidance; adj. EPS $1.06, organic rev +2%
GE HealthCare Technologies Inc.
2025-Q2 EPS
reported $2.29
vs consensus $0.94
▲ beat
(+144.7%)
- Q2 revenue $5.0B, organic growth 2%; net income $486M vs $428M YoY.
- Adjusted EPS $1.06 vs $1.00 YoY; cash from ops $94M vs ($119M) YoY.
- Raises FY guidance: organic rev ~3%, adj. EBIT margin 15.2%-15.4%, adj. EPS $4.43-$4.63.
- Segment highlights: Imaging EBIT margin 8.5% (-110bps), PD revenue +14%.
- Tariff impact ~$0.45/share in updated guidance; new FCF target at least $1.4B.